HempNewsBreaks – Therma Bright Inc.’s (TSX.V: THRM) (OTC: THRBF) TherOZap(TM) Technology in Final Stage Testing Against Zika Virus

Medical device technology provider Therma Bright (TSX.V: THRM) (OTC: THRBF) this morning announced that it is in the final stages of in vitro testing and awaits the results of the TherOZap(TM) technology against the Zika virus. According to the update, a top research laboratory in Canada is conducting the testing, and Therma Bright expects to report further information as it becomes available. “To date the research lab has done an excellent job following protocol and testing our device with the aim of reporting statistically relevant results,” Therma Bright CEO Rob Fia stated in the news release. “Therma Bright made a number of improvements to the device for this testing and we look forward to reporting the test results of our TherOZap(TM) technology against the Zika in the near future.”

To view the full press release, visit http://cnw.fm/PSgA0

About Therma Bright Inc.

Therma Bright is a progressive medical-device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of the company’s philosophy, as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments. The company’s breakthrough proprietary technology delivers effective, noninvasive and pain-free skin care. For more information, visit the company’s website at www.ThermaBright.com.

NOTE TO INVESTORS: The latest news and updates relating to THRBF are available in the company’s newsroom at http://cnw.fm/THRBF

About HempWire

HempWire (HW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) HempNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, HW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. HW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, HW brings its clients unparalleled visibility, recognition and brand awareness. HW is where news, content and information converge.

To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.hempwire.com

Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/disclaimer/

Do you have a questions or are you interested in working with HW? Ask our Editor

HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net